Scientific article
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
ContributorsLopes Alves, Isadora; Collij, Lyduine E; Altomare, Daniele; Frisoni, Giovanni; Saint-Aubert, Laure; Payoux, Pierre; Kivipelto, Miia; Jessen, Frank; Drzezga, Alexander; Leeuwis, Annebet; Wink, Alle Meije; Visser, Pieter Jelle; van Berckel, Bart N M; Scheltens, Philip; Gray, Katherine R; Wolz, Robin; Stephens, Andrew; Gismondi, Rossella; Buckely, Christopher; Gispert, Juan Domingo; Schmidt, Mark; Ford, Lisa; Ritchie, Craig; Farrar, Gill; Barkhof, Frederik; Molinuevo, José Luis; AMYPAD Consortium
Published inAlzheimer's & Dementia, vol. 16, no. 5, p. 750-758
Publication date2020
Abstract
Keywords
- Amyloid
- Positron emission tomography imaging
- Preclinical and prodromal Alzheimer's disease
- Secondary prevention
Affiliation entities
Research groups
Funding
- European Commission - Amyloid imaging to Prevent Alzheimer's Disease – Sofia ref.: 115952 [115952]
Citation (ISO format)
LOPES ALVES, Isadora et al. Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study. In: Alzheimer’s & Dementia, 2020, vol. 16, n° 5, p. 750–758. doi: 10.1002/alz.12069
Main files (1)
Article (Published version)
Identifiers
- PID : unige:140407
- DOI : 10.1002/alz.12069
- PMID : 32281303
Journal ISSN1552-5260
